Author
City Of Hope National Medical CenterORCID 0009-0006-0607-1784Unclaimed ORCID profile · follow to get notified of new preprints
Mutual co-authors in cluster
5 papers
Recent·Most cited
Fernando C. Diaz, Brigette Waldrup, Francisco Carranza…·Enrique I. Velazquez-Villarreal
The paper uses AI to analyze genomic data from colorectal cancer patients, finding TP53 pathway alterations are linked to better survival in Hispanic/Latino patients treated with FOLFOX.
Fernando C. Diaz, Brigette Waldrup, Francisco Carranza…·Enrique I. Velazquez-Villarreal
This study examines WNT pathway alterations in early-onset colorectal cancer across different populations and treatment groups, finding ancestry-specific effects of FOLFOX chemotherapy on mutation frequencies and survival outcomes.
Fernando C. Diaz, Brigette Waldrup, Francisco Carranza…·Enrique I. Velazquez-Villarreal
The paper identifies PI3K pathway alterations as a prognostic biomarker in early-onset colorectal cancer patients receiving FOLFOX and highlights ancestry-specific mutational differences using AI tools.
Fernando C. Diaz, Brigette Waldrup, Francisco Carranza…·Enrique I. Velazquez-Villarreal
The paper uses AI to analyze genomic and clinical data from colorectal cancer patients, finding that TGF-beta pathway alterations predict poorer survival in Hispanic/Latino patients treated with FOLFOX.
Cecilia Monge, Brigette Waldrup, Sophia Manjarrez…·Enrique I. Velazquez-Villarreal
This study identifies higher PI3K and mTOR pathway alterations in early-onset CRC among Hispanic/Latino patients compared to non-Hispanic White patients, with improved outcomes linked to TP53 alterations.